 |
市场调查报告书
商品编码
2008049
动物疫苗市场：依产品类型、应用、通路和地区划分。Animal Vaccines Market, By Product Type, By Application, By Distribution Channel, By Geography |
||||||
预计到2026年，动物疫苗市场规模将达到98.157亿美元，2033年将达到152.756亿美元。预计从2026年到2033年，其复合年增长率将达到6.6%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2025 | 2026年市场规模： | 98.157亿美元 |
| 历史数据时期： | 2020年至2024年 | 预测期： | 2026年至2033年 |
| 2026年至2033年预测期间的复合年增长率： | 6.60% | 2033年市场规模预测： | 152.756亿美元 |
动物疫苗是用于预防和治疗各种兽医疾病的注射剂型。它们在经济有效地维护宠物和牲畜的健康、寿命和整体生产力方面发挥着至关重要的作用。伴侣动物疫苗有助于预防各种疾病从动物传播给人类。这些疫苗是注射剂型，用于预防和治疗多种疾病，包括芽生菌病、鹦鹉热和猫抓病。
市场动态
疫苗是用于预防多种疾病的药物。有些疫苗价格昂贵且难以取得。因此，全球动物疫苗市场的许多公司都提供报销方案，以减轻宠物疫苗接种的费用，预计这将推动预测期内的市场成长。例如，使用 ULTRA Duramune DAP 组合疫苗和 Bronchi-Shield ORAL 口服疫苗治疗的犬隻，Elanco 将报销因犬副流感病毒感染而导致呼吸道疾病的诊断和治疗的常规费用（最高 5,000 美元）。此外，Elanco 还将报销用于确诊的标准且合理的诊断测试（切片检查和组织病理学检查）的费用。如果确诊，Elanco 将报销最高 1,500 美元的标准且合理的治疗费用。对于接受「ULTRA Duramune DAP」联合疫苗和「Bronchi-Shield ORAL」治疗的犬隻，Elanco 将报销与犬副流感病毒感染引起的呼吸道疾病的诊断和治疗相关的通常和惯常费用（最高 5,000 美元）。
此外，多家宠物健康保险公司提供疫苗接种、身体检查、洗牙、绝育以及其他宠物健康相关活动的保险。这些宠物健康保险公司包括美国预防虐待动物协会宠物保险 (ASPCA Pet Insurance)、PetFirst 保险、Embrace 宠物保险代理公司、PetPlan 和 Allstate 保险公司。
本次调查的主要特点。
- 本报告对预测期（2021-2028 年）内全球动物疫苗市场的规模进行了详细分析，以 2020 年为基准年。
- 本报告指出了各个细分市场的潜在商机，并说明了该市场中一系列有吸引力的投资提案。
- 此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
- 本报告根据以下参数对全球动物疫苗市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务绩效和策略。
- 透过利用本报告中提出的见解，企业行销负责人和经营团队可以就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
- 本报告面向该产业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
- 透过分析全球动物疫苗市场时所使用的各种策略矩阵，相关人员将能够更轻鬆地做出决策。
目录
第一章：研究目标与前提条件
- 研究目标
- 前提
- 简称
第二章 市场范围
- 报告摘要
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章：市场动态、监管与趋势分析
- 促进因素和阻碍因素
- 机会
- 影响分析
- 主要进展
- 新产品发布
- 合作关係与协议
- 科技趋势
- 品牌分析
- 法规环境
- 流行病学
- 兑换系统
- 波特五力分析
第四章 全球动物疫苗市场：依产品类型划分，2026-2033年
- 减毒活病毒疫苗
- 结合疫苗
- 灭活疫苗
- 次单位疫苗
- 类毒素疫苗
- DNA疫苗
- 基因改造疫苗
第五章 全球动物疫苗市场：依应用领域划分，2026-2033年
- 伴侣动物
- 家畜
- 家禽
- 水产养殖
第六章：全球动物疫苗市场：依通路划分，2026-2033年
- 兽医诊所
- 动物医院
- 兽医研究所
- 其他的
第七章 全球动物疫苗市场：依地区划分，2026-2033年
- 北美洲
- 我们
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 亚太其他地区
- 中东
- GCC
- 以色列
- 其他中东国家
- 非洲
- 北非
- 中非
- 南非
第八章 竞争情势
- 公司简介
- Merck &Co., Inc.
- Boehringer Ingelheim International GmbH
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Ceva
- HIPRA
- Romvac Company Sa
- Biovac
- Vaxxinova International BV
- Biogenesis Bago
第九章
- 调查方法
- 关于本公司
Animal Vaccines Market is estimated to be valued at USD 9,815.7 Mn in 2026 and is expected to reach USD 15,275.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9,815.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.60% | 2033 Value Projection: | USD 15,275.6 Mn |
Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Animal vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. These vaccines are parenteral products that are used in prophylactic treatment of various diseases such as blastomycosis, psittacosis cat scratch disease, and others.
Market Dynamics
Vaccines are preventive medicines for the treatment of various diseases. Some of the vaccines are expensive to afford. So various companies operating in the global animal vaccines market offer reimbursement to reduce the expenses of pet vaccinations which is expected to augment the market growth over the forecast period. For instance, For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection Moreover, Elanco reimburses standard and reasonable diagnostics (a biopsy and histopathological exam) to reach a definitive diagnosis. With a confirmed diagnosis, Elanco reimburses standard and reasonable treatment costs up to US$ 1,500. For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection.
Moreover, various pet health insurance companies provide coverage for vaccines, examinations, teeth cleaning, spaying, and other pet health related activities. Some of the pet health insurance companies include ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, and PetPlan, Allstate Insurance Company, among others.
Key features of the study
- This report provides an in-depth analysis of the global animal vaccines market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global animal vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
- Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogenesis Bago
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global animal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal vaccines market
Market Segmentation
- By Product Type
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- By Application
- Companion Animal
- Livestock Animal
- Poultry
- Aquaculture
- By Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH.
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Ceva
- HIPRA
- Romvac Company Sa
- Biovac
- Vaxxinova International BV
- Biogenesis Bago
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers and Restraints
- Opportunities
- Impact Analysis
- Key developments
- New Product Launches
- Partnerships and Agreements
- Technological Landscape
- Brand Analysis
- Regulatory Scenario
- Epidemiology
- Reimbursement Schemes
- PORTER Analysis
4. Global Animal Vaccines Market, By Product Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2021 and 2032 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Attenuated Live Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Inactivated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- DNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
5. Global Animal Vaccines Market, By Application, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2021 and 2032 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Companion Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Livestock Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Poultry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Aquaculture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
6. Global Animal Vaccines Market, By Distribution Channel, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2021 and 2032 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Veterinary Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
7. Global Animal Vaccines Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- HIPRA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Romvac Company Sa
- Company Highlights
- Product Portfolio
- Key Highlights
- Strategies
- Biovac
- Company Highlights
- Product Portfolio
- Key Highlights
- Strategies
- Vaxxinova International BV
- Company Highlights
- Product Portfolio
- Key Highlights
- Strategies
- Biogenesis Bago
- Company Highlights
- Product Portfolio
- Key Highlights
- Strategies
- Merck & Co., Inc.
9. Section
- Research Methodology
- About Us
梭菌疫苗市场：2026-2032年全球市场预测（按疫苗类型、目标疾病、给药途径、通路和最终用户划分）兽用疫苗市场：按产品类型、目标动物、给药途径、疾病类型和分销管道分類的全球市场预测，2026-2032年猪疫苗市场：依疫苗类型、目标疾病、最终用户、给药途径、技术和剂型划分－2026-2032年全球市场预测伴侣动物疫苗市场：依动物类型、疫苗类型、给药途径及通路划分－2026-2032年全球市场预测犬用疫苗市场：2026年至2032年全球市场预测（依疫苗类型、科技、动物年龄层、通路和最终用户划分）兽用抗生素市场：按类别、动物类型、最终用户和治疗领域划分－全球预测，2026-2032年
鸭用药品和疫苗市场：按类型、应用和地区划分全球畜牧育种市场（按品种、育种目的、育种系统和技术以及分销管道划分）预测（2026-2032年）兽用角膜护理镜片市场（依动物种类、产品类型、通路和应用划分）－全球预测，2026-2032年牛疫苗市场：依疫苗类型、疾病适应症、牛类型、给药途径、最终用户、分销管道和地区划分。